Harbor ETF Trust. Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Eli Lilly & CoLLY | 20.78% | $8.56M | 7,455 |
| Ascendis Pharma A/S | 13.61% | $5.61M | 22,993 |
| Gilead Sciences IncGILD | 5.10% | $2.10M | 16,135 |
| Rhythm Pharmaceuticals IncRYTM | 4.02% | $1.66M | 16,680 |
| AbbVie IncABBV | 3.09% | $1.27M | 5,079 |
| Intuitive Surgical IncISRG | 2.83% | $1.17M | 3,300 |
| Cencora IncCOR | 2.75% | $1.13M | 3,634 |
| Revolution Medicines IncRVMD | 2.54% | $1.05M | 5,583 |
| Insmed IncINSM | 2.52% | $1.04M | 10,513 |
| Merck & Co IncMRK | 2.47% | $1.02M | 7,807 |
| Boston Scientific CorpBSX | 2.40% | $989.09K | 21,166 |
| Natera IncNTRA | 2.26% | $930.47K | 3,475 |
| Abivax SAABVX | 2.16% | $891.80K | 7,139 |
| Insulet CorpPODD | 2.10% | $864.12K | 5,226 |
| Argenx SEARGX | 2.07% | $854.67K | 1,001 |
| Vaxcyte IncPCVX | 2.06% | $848.79K | 15,695 |
| McKesson CorpMCK | 2.02% | $833.93K | 974 |
| Legend Biotech CorpLEGN | 1.91% | $786.80K | 42,415 |
| Danaher CorpDHR | 1.73% | $711.09K | 3,647 |
| Guardant Health IncGH | 1.54% | $635.81K | 3,925 |
| Novo Nordisk A/SNVO | 1.46% | $601.68K | 12,780 |
| IDEXX Laboratories IncIDXX | 1.40% | $578.08K | 1,034 |
| UnitedHealth Group IncUNH | 1.39% | $572.70K | 1,382 |
| PTC Therapeutics IncPTCT | 1.31% | $538.16K | 7,913 |
| Vertex Pharmaceuticals IncVRTX | 1.22% | $502.39K | 1,053 |
| Alnylam Pharmaceuticals IncALNY | 1.21% | $499.41K | 2,430 |
| Thermo Fisher Scientific IncTMO | 1.16% | $479.54K | 835 |
| Adaptive Biotechnologies CorpADPT | 0.98% | $402.99K | 17,855 |
| Madrigal Pharmaceuticals IncMDGL | 0.93% | $381.80K | 817 |
| Praxis Precision Medicines IncPRAX | 0.91% | $375.86K | 1,221 |
| Dexcom IncDXCM | 0.81% | $332.05K | 3,979 |
| RadNet IncRDNT | 0.80% | $328.21K | 5,146 |
| Penumbra IncPEN | 0.77% | $317.01K | 987 |
| Relay Therapeutics IncRLAY | 0.64% | $264.35K | 14,039 |
| Oruka Therapeutics IncORKA | 0.60% | $245.71K | 2,546 |
| IRhythm Holdings IncIRTC | 0.58% | $237.27K | 2,025 |
| Viatris IncVTRS | 0.57% | $235.73K | 13,424 |
| Newamsterdam Pharma Co NV | 0.52% | $212.76K | 7,656 |
| Xenon Pharmaceuticals IncXENE | 0.51% | $210.70K | 3,362 |
| Indivior Pharmaceuticals IncINDV | 0.50% | $205.81K | 5,144 |
| Axsome Therapeutics IncAXSM | 0.49% | $202.51K | 929 |
| Inventiva SACAIVA | 0.37% | $152.30K | 33,996 |
| Sophia Genetics SA | 0.33% | $137.59K | 24,267 |
| Ionis Pharmaceuticals IncIONS | 0.20% | $84.44K | 1,631 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.